CINECA IRIS Institutional Research Information System

RAPA, IDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.631
EU - Europa 2.353
AS - Asia 1.848
SA - Sud America 94
AF - Africa 42
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 6
Totale 9.010
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.554
CN - Cina 922
IT - Italia 619
SG - Singapore 335
DE - Germania 245
IE - Irlanda 244
SE - Svezia 243
FR - Francia 180
FI - Finlandia 136
UA - Ucraina 135
IN - India 121
GB - Regno Unito 100
KR - Corea 92
JP - Giappone 91
VN - Vietnam 84
PL - Polonia 83
AT - Austria 72
ES - Italia 66
CA - Canada 60
BR - Brasile 49
ID - Indonesia 42
DK - Danimarca 41
TR - Turchia 40
NL - Olanda 36
BE - Belgio 34
AU - Australia 31
HK - Hong Kong 31
SN - Senegal 28
RU - Federazione Russa 23
GR - Grecia 19
AR - Argentina 18
CL - Cile 17
CH - Svizzera 16
IL - Israele 15
MX - Messico 15
RO - Romania 15
NO - Norvegia 10
SA - Arabia Saudita 10
TW - Taiwan 10
UZ - Uzbekistan 10
CZ - Repubblica Ceca 8
PT - Portogallo 8
MY - Malesia 7
QA - Qatar 7
TH - Thailandia 7
EU - Europa 6
EG - Egitto 5
HR - Croazia 5
HU - Ungheria 5
IR - Iran 5
PE - Perù 5
PH - Filippine 5
NZ - Nuova Zelanda 4
IQ - Iraq 3
CO - Colombia 2
EC - Ecuador 2
LT - Lituania 2
NG - Nigeria 2
NP - Nepal 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BG - Bulgaria 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
FJ - Figi 1
GE - Georgia 1
GT - Guatemala 1
KG - Kirghizistan 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MW - Malawi 1
RS - Serbia 1
SC - Seychelles 1
SD - Sudan 1
SI - Slovenia 1
TG - Togo 1
TN - Tunisia 1
VE - Venezuela 1
Totale 9.010
Salva come PNG Salva come JPEG
Città #
Chandler 498
Beijing 366
Santa Clara 328
Fairfield 305
Houston 287
Singapore 271
Dublin 239
Ann Arbor 223
Ashburn 219
Torino 161
Woodbridge 161
Wilmington 139
Redwood City 136
Seattle 124
Pisa 109
Nyköping 103
Cambridge 102
Dearborn 97
Villeurbanne 93
Princeton 76
Fremont 75
Medford 73
Jacksonville 71
Dong Ket 69
Vienna 69
Warsaw 66
Shanghai 59
Columbus 58
Milan 48
Guangzhou 45
Nanjing 45
New York 44
Jakarta 38
Turin 37
Boston 35
Boardman 34
Munich 31
Helsinki 30
Hangzhou 27
Brussels 24
Los Angeles 24
Pune 24
San Diego 23
Chengdu 21
Istanbul 20
Kunming 19
Norwalk 19
Düsseldorf 18
Wuhan 18
Zhengzhou 18
Changsha 17
Madrid 17
Shenyang 15
Phoenix 14
Tokyo 14
Washington 14
Bethesda 13
Erlangen 13
Hefei 13
León 13
Rome 13
Silver Spring 13
London 12
Barcelona 11
Eitensheim 11
Hong Kong 11
Santiago 11
Seoul 11
Toronto 11
Zurich 11
Buffalo 9
Falls Church 9
Hebei 9
São Paulo 9
Tappahannock 9
Xian 9
Bangalore 8
Padova 8
Rotterdam 8
Suzhou 8
Denver 7
Jinan 7
Mountain View 7
Oslo 7
Paris 7
Rzeszów 7
Upper Marlboro 7
Amsterdam 6
Athens 6
Berlin 6
Chicago 6
Duncan 6
Gurgaon 6
Lyon 6
Mexico 6
Mont-saint-aignan 6
Napoli 6
Nürnberg 6
Rio de Janeiro 6
Stanford 6
Totale 5.690
Salva come PNG Salva come JPEG
Nome #
IMPACT OF PREGNANCY ON PROGNOSIS OF DIFFERENTIATED THYROID CANCER: CLINICAL AND MOLECULAR FEATURES. 461
RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact 352
microRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations 329
Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study 326
Functional Role and Prognostic Significance of CD157 in Ovarian Carcinoma 322
Thymidylate synthase is functionally associated with ZEB1 and contributes to the epithelial-to-mesenchymal transition of cancer cells 303
Therapeutic Biomarkers in Lung Neuroendocrine Neoplasia 302
Personalized therapeutic strategies in HER2-driven gastric cancer 264
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization 257
Mammalian target of rapamycin pathway activation is associated to RET mutation status in medullary thyroid carcinoma. 245
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines. 242
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 219
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 212
mTORC1 Complex is Significantly Over-Activated in SDHX-Mutated Paragangliomas 202
H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features data from a multi-institutional series 201
CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome. 190
Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung. 190
Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer 174
Impact of non-small-cell lung cancer-not otherwise specified immunophenotyping on treatment outcome. 144
Biological role and clinical significance of CD157 in epithelial ovarian cancer 143
Clinical and biological significance of CD157 in malignant pleural mesothelioma 140
Mechanical phenotyping of cells and extracellular matrix as grade and stage markers of lung tumor tissues 139
Biological role, clinical significance and potential therapeutic applications of CD157 in ovarian cancer 132
Ribonucleotide Reductase Large Subunit (RRM1) Gene Expression May Predict Efficacy of Adjuvant Mitotane in Adrenocortical Cancer. 127
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells 127
Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma 120
CD157: A New Prognostic and/or Predictive Marker in Ovarian Cancer? A Retrospective Study 118
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine 116
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 115
CD157 is a novel prognostic marker of malignant pleural mesothelioma involved in the control of tumor aggressiveness 112
CD157 CONTROLS PERITONEAL DISSEMINATION AND INVASION OF OVARIAN CARCINOMA AND IS A MOLECULAR PREDICTOR OF POOR CLINICAL OUTCOME 107
Clinical and biological significance of CD157 in ovarian carcinoma 105
CD157 as a potential pleural effusion biomarker for malignant mesothelioma 103
Images in Endocrine Pathology: Unique Composite Adrenal Adenomatoid Tumor, Ganglioneuroma, Myelolipoma, and Cortical Nodular Hyperplasia 101
Androgen deprivation modulates gene expression profile along prostate cancer progression 101
Identification of MicroRNAs Differentially Expressed in Lung Carcinoid Subtypes and Progression 100
Absence of RET gene point mutations in sporadic thyroid C-cell hyperplasia. 97
Tissue Expression and Pharmacological In Vitro Analyses of mTOR and SSTR Pathways in Adrenocortical Carcinoma 96
High miR-100 expression is associated with aggressive features and modulates TORC1 complex activation in lung carcinoids 93
Proton pump inhibitors promote the growth of androgen-sensitive prostate cancer cells through ErbB2, ERK1/2, PI3K/Akt, GSK-3β signaling and inhibition of cellular prostatic acid phosphatase 93
Tumor/Stromal caveolin-1 expression patterns in pleural mesothelioma define a subgroup of the epithelial histotype with poorer prognosis 90
Dissecting morphological and molecular heterogeneity in adrenocortical carcinoma 90
Multiple Assays to Determine Methylguanine-Methyltransferase Status in Lung Carcinoids and Correlation with Clinical and Pathological Features 89
CD157: A NEW PROGNOSTIC MARKER IN OVARIAN CANCER 86
Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy 83
Human ASH-1 Promotes Neuroendocrine Differentiation in Androgen Deprivation Conditions and Interferes With Androgen Responsiveness in Prostate Cancer Cells. 78
Obestatin in human neuroendocrine tissues and tumours: expression and effect on tumour growth 76
Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer 75
Achaete-scute homolog 1 as a marker of poorly differentiated neuroendocrine carcinomas of different sites: a validation study using immunohistochemistry and quantitative real-time polymerase chain reaction on 335 cases 75
Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase 75
Neuro-endocrine tumours of the lung. A review of relevant pathological and molecular data 74
Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomas 73
mTOR pathway activation in multiple myeloma cell lines and primary tumour cells: pomalidomide enhances cytoplasmic-nuclear shuttling of mTOR protein 72
Differential expression profiles of cell-to-matrix-related molecules in adrenal cortical tumors: Diagnostic and prognostic implications 72
[Immunohistochemistry in thyroid needle aspiration samples] 67
Cathepsin K is selectively expressed in the stroma of lung adenocarcinoma but not in bronchioloalveolar carcinoma. A useful marker of invasive growth 66
Poorly differentiated thyroid carcinoma: diagnostic features and controversial issues 64
Human ASH1 expression in prostate cancer with neuroendocrine differentiation 64
Expression and pharmacological inhibition of thymidilate synthase and Src kinase in non-small cell lung cancer. 57
High interlaboratory and interobserver agreement of somatostatin receptor immunohistochemical determination and correlation with response to somatostatin analogs 53
Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors 52
Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition 50
Proposal of a Panel of Genes Identified by miRNA Profiling as Candidate Prognostic Biomarkers in Lung Carcinoids 48
Primary lung adenocarcinoma in three adolescent patients affected by bone sarcomas 48
Thymidylate synthase drives the phenotypes of epithelial-to-mesenchymal transition in non-small cell lung cancer 47
The Oncocytic Variant of Poorly Differentiated Thyroid Carcinoma Shows a Specific Immune-Related Gene Expression Profile 43
Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer 40
Human achaete-scute homolog-1 expression in neuroendocrine breast carcinoma. 37
Galectin-3 immunohistochemical detection in the differential diagnosis of parathyroid lesions 30
Molecular Subtypes of Extra-pulmonary Neuroendocrine Carcinomas Identified by the Expression of Neuroendocrine Lineage-Specific Transcription Factors 29
Targeting the multidrug transporter Patched potentiates chemotherapy efficiency on adrenocortical carcinoma in vitro and in vivo. 28
MicroRNA profiling predicts positive nodal status in papillary thyroid carcinoma in the preoperative setting 22
Totale 9.273
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.400
article - articoli 0
book - libri 0
conference - conferenze 2.601
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.001
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020957 0 0 0 0 0 250 166 137 122 145 62 75
2020/20211.034 69 84 80 65 99 89 84 61 94 97 53 159
2021/20221.161 87 87 70 96 65 59 62 82 48 83 237 185
2022/20231.522 127 108 60 148 155 340 98 113 185 44 77 67
2023/2024828 91 125 43 52 68 117 39 85 14 56 62 76
2024/20251.042 27 128 76 168 517 126 0 0 0 0 0 0
Totale 9.273